Integrated BioPharma, Inc.

INBP · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$4,732$3,615$2,961$2,461
Short-Term Investments$0$0$0$0
Receivables$3,983$5,430$5,080$4,228
Inventory$10,469$9,362$10,077$11,066
Other Curr. Assets$440$356$428$398
Total Curr. Assets$19,624$18,763$18,546$18,153
Property Plant & Equip (Net)$2,595$2,749$2,874$3,094
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$3,269$3,337$4,109$4,353
Other NC Assets$52$52$54$61
Total NC Assets$5,916$6,138$7,037$7,508
Other Assets$0$0$73$0
Total Assets$25,540$24,901$25,656$25,661
Liabilities
Payables$2,800$2,267$2,501$2,808
Short-Term Debt$474$679$0$964
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,490-$679$0$1,803
Total Curr. Liab.$4,764$4,248$4,981$5,575
LT Debt$287$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$287$336$292$359
Other Liabilities$0$0$0$0
Cap. Leases$761$1,015$1,136$1,323
Total Liabilities$5,051$4,584$5,273$5,934
Equity
Pref Stock$0$0$0$0
Common Stock$0$62$61$61
Retained Earnings-$31,296-$31,419-$31,241-$31,852
AOCI$0$0$0$0
Other Equity$51,785$0$0$0
Total Equity$20,489$20,317$20,383$19,727
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$25,540$24,901$25,656$25,661
Net Debt-$3,971-$2,936-$2,961-$1,497